11 results
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
or any other person authorized by the Board or the President is authorized to vote, represent and exercise on behalf of the Company all rights incident
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
Effect. There is no, and has been no, breach, security incident, or accidental, unlawful, or unauthorized access to, or other Processing of, Company
8-K
EX-1.1
STSA
Satsuma Pharmaceuticals Inc
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
expenses incident to the performance of its obligations hereunder, including expenses relating to (i) the preparation, printing and filing
S-3
EX-1.2
STSA
Satsuma Pharmaceuticals Inc
23 Oct 20
Shelf registration
4:48pm
hereunder are consummated or this Agreement is terminated in accordance with the provisions of Section 11 hereunder, will pay all expenses incident
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
17 Sep 19
Satsuma Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
4:11pm
to vote, represent and exercise on behalf of this Corporation all rights incident to any and all shares of any other corporation or corporations
S-1/A
EX-1.1
54ie3kli yzc2037h
3 Sep 19
IPO registration (amended)
6:12am
S-1
EX-4.3
tr4zonqn
16 Aug 19
IPO registration
5:15pm
S-1
EX-3.4
cadh9lchx58
16 Aug 19
IPO registration
5:15pm
S-1
EX-3.5
gsuqgnhapib1 c09xqe
16 Aug 19
IPO registration
5:15pm
DRS/A
EX-3.5
h7bdcpqkkhrj
2 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-3.4
em8q4qw6 tiwh
2 Aug 19
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next